Back to top
more

Edwards Lifesciences (EW)

(Real Time Quote from BATS)

$66.49 USD

66.49
3,787,671

+0.26 (0.39%)

Updated Nov 11, 2024 03:52 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Abbott (ABT) Q3 Earnings Top Estimates, Guidance Narrowed

by Zacks Equity Research

Within Structural Heart, growth was driven by several product areas across Abbott's (ABT) broad portfolio, including AMPLATZER PFO Occluder and MitraClip.

Kevin Cook headshot

Bear of the Day: Newmont Mining (NEM)

by Kevin Cook

Gold back above $1200 is encouraging for miners, but the long-term bear market is still in charge

Edwards Lifesciences (EW) Q3 Earnings Preview: Here's What to Look Out For

by Zacks Equity Research

Edwards Lifesciences (EW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is Edwards Lifesciences (EW) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (EW) Outperforming Other Medical Stocks This Year?

Can Edwards Lifesciences (EW) Keep the Earnings Surprise Streak Alive?

by Zacks Equity Research

Edwards Lifesciences (EW) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Edwards Begins US CENTERA Study, Reintroduces Valve in Europe

by Zacks Equity Research

Edwards (EW) is recommencing commercial introduction of CENTERA valve in Europe after making certain minor modification to CENTERA's delivery system.

Zacks Market Edge Highlights: Intuitive Surgical, BioTelemetry, Edwards Lifesciences, Penumbra and Vericel

by Zacks Equity Research

Zacks Market Edge Highlights: Intuitive Surgical, BioTelemetry, Edwards Lifesciences, Penumbra and Vericel

    Tracey Ryniec headshot

    How to Invest in the Hot Medical Device Innovators

    by Tracey Ryniec

    Forget the biotechs. Medical device companies are innovating in amazing ways. Here's how to invest.

      Sweta Jaiswal headshot

      4 MedTech Stocks to Counter Mounting US-China Trade Tensions

      by Sweta Jaiswal

      In the wake of the impact of the U.S.-China trade war on the MedTech space, we have doubled down on some stocks which offer a safe haven to investors.

        Here's Why You Should Add Edwards Lifesciences Right Away

        by Zacks Equity Research

        We are upbeat about the continued strength in Edwards Lifesciences' (EW) THVT business.

          Edwards Lifesciences (EW) in Focus: Stock Moves 7.7% Higher

          by Zacks Equity Research

          Edwards Lifesciences (EW) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

            Kevin Cook headshot

            Bull of the Day: Penumbra (PEN)

            by Kevin Cook

            Innovation in stroke treatment with catheter-based technologies has launched a new rocket of med-tech

              Here's Why You Should Steer Clear of AmerisourceBergen Now (Revised)

              by Zacks Equity Research

              AmerisourceBergen (ABC) continues to witness headwinds due to slowdown in hepatitis C revenues and conversion of branded drugs to the lower price generics.

                Edwards Lifesciences (EW) Q2 Earnings Beat, Revenues Miss

                by Zacks Equity Research

                Edwards Lifesciences (EW) gains from THVT strength on continued therapy adoption across all geographies in Q2.

                  Medical Product Earnings Lineup for Jul 26: BAX, EW & More

                  by Zacks Equity Research

                  Streak of regulatory developments and deep R&D focus are likely to drive the Medical Product industry this earnings season. Here we take a quick look at four Medical Product majors that are going to release earnings results.

                    Can R&D Focus Drive DENTSPLY SIRONA's (XRAY) Q2 Earnings?

                    by Zacks Equity Research

                    DENTSPLY SIRONA's (XRAY) continued focus on research and development and strategic buyouts are likely to drive Q2 results.

                      What's in Store for Cerner (CERN) This Earnings Season?

                      by Zacks Equity Research

                      Cerner's (CERN) Q2 results are likely to show softer performance owing to declining revenues across core business segments.

                        What's in Store for AmerisourceBergen (ABC) in Q3 Earnings?

                        by Zacks Equity Research

                        AmerisourceBergen's (ABC) Q3 results are likely to be driven by its core Pharmaceutical Distribution business; a competitive industry is a headwind.

                          Will Edwards' (EW) Steady Overall Growth Drive Q2 Earnings?

                          by Zacks Equity Research

                          Edwards Lifesciences (EW) expected to gain from strength in all business segments and geographies in Q2.

                            Can BD Medical Drive Becton, Dickinson's (BDX) Q3 Earnings?

                            by Zacks Equity Research

                            Becton, Dickinson's (BDX) core BD Medical likely to register solid results in Q3; a possible decline in BD Life Sciences raises concern.

                              Can Business Services Aid athenahealth's (ATHN) Q2 Earnings?

                              by Zacks Equity Research

                              athenahealth's (ATHN) core Business Services unit is likely to drive growth in Q2; the company's focus on cloud-based services is encouraging.

                                Can Overall Growth Drive Align Technology (ALGN) Q2 Earnings?

                                by Zacks Equity Research

                                Align Technology (ALGN) likely to gain from strength in Invisalign space as well as Scanner and Service business in Q2.

                                  Here's Why You Should Add Edwards Lifesciences (EW) Now

                                  by Zacks Equity Research

                                  We are upbeat about Edwards Lifesciences' (EW) strong transcatheter valve sales in the domestic market as well as overseas.

                                    Kevin Cook headshot

                                    Bear of the Day: Barrick Gold (ABX)

                                    by Kevin Cook

                                    Growth estimates were falling when gold was rising, thus not surprising to see them slip further

                                      Sweta Killa headshot

                                      Should iShares Morningstar Mid-Cap Growth ETF (JKH) Be on Your Investing Radar?

                                      by Sweta Killa

                                      Style Box ETF report for JKH